Curis (NASDAQ:CRIS) Now Covered by StockNews.com
Research analysts at StockNews.com assumed coverage on shares of Curis (NASDAQ:CRIS – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright cut their target price on Curis from $20.00 to $16.00 and set a “buy” rating for the company […]
Research analysts at StockNews.com assumed coverage on shares of Curis (NASDAQ:CRIS – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright cut their target price on Curis from $20.00 to $16.00 and set a “buy” rating for the company […]